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Abstract
Background: The rise in multimorbid chronic conditions in South Africa, large treatment gap for common mental
disorders (CMDs) and shortage of mental health specialists demands a task sharing approach to chronic disease
management that includes treatment for co-existing CMDs to improve health outcomes. The aim of this study was
thus to evaluate a task shared integrated collaborative care package of care for chronic patients with co-existing
depressive and alcohol use disorder (AUD) symptoms.
Methods: The complex intervention strengthened capacity of primary care nurse practitioners to identify, diagnose
and review symptoms of CMDs among chronic care patients; and implemented a stepped up referral system, that
included clinic-based psychosocial lay counsellors, doctors and mental health specialists. Under real world conditions,
in four PHC facilities, a repeat cross-sectional Facility Detection Survey (FDS) assessed changes in capacity of nurses to
correctly detect CMDs in 1310 patients before implementation and 1246 patients following implementation of the
intervention at 12months; and a non-randomly assigned comparison group cohort study comprising 373 screen
positive patients with depressive symptoms using the Patient Health Questionnaire-9 (PHQ9) at baseline, evaluated
responses of patients correctly identified and referred for treatment (intervention arm) or not identified and referred
(control arm) at three and 12months.
Results: The FDS showed a significant increase in the identification of depression and AUD from pre-implementation to
12-month post-implementation. Depression: (5.8 to 16.4%) 95% CI [2.9, 19.1]); AUD: (0 to 13.8%) 95% CI [0.6–24.9]. In the
comparison group cohort study, patients with depressive symptoms having more than a 50% reduction in PHQ-9 scores
were greater in the treatment group (n = 69, 55.2%) compared to the comparison group (n = 49, 23.4%) at 3months (RR
= 2.10, p < 0.001); and 12months follow-up (intervention: n = 57, 47.9%; comparison: n = 60, 30.8%; RR = 1.52, p = 0.006).
Remission (PHQ-9≤ 5) was greater in the intervention group (n = 32, 26.9%) than comparison group (n = 33, 16.9%) at
12months (RR = 1.72, p = 0.016).
Conclusion: A task shared collaborative stepped care model can improve detection of CMDs and reduce depressive
symptoms among patients with chronic conditions under real world conditions.
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Background
Mental disorders are on the rise globally, and are often co-
morbid with other chronic conditions, being two to five
times more prevalent in people with chronic physical
health conditions than the rest of the population [1–4].
Mental-physical comorbidities are associated with greater
decrements in health outcomes [1] and increased health
care utilization costs [5]. The need for chronic disease
management to include treatment for co-existing
common mental disorders (CMDs) is thus increasingly
viewed as a priority in the global challenge of care for
multi-morbidity [6].
South Africa is one of a growing number of low- and
middle-income countries (LMICs) experiencing a rising
burden of multi-morbid chronic conditions [7]. This is a
consequence of the transition of HIV to a chronic condi-
tion with the scale-up of antiretroviral treatment; as well
as the intensifying non-communicable disease (NCD)
burden. In response the South African Department of
Health has pioneered an Integrated Clinical Services
Management (ICSM) approach that strives to service the
majority of patients in primary health care (PHC) at a
single delivery point using integrated clinical chronic
care guidelines [8]. Integration of mental health care is
part of ICSM in South Africa, but has been shown to be
inadequate [9]; with a treatment gap of 75% for CMDs
in South Africa [10]. While there is evidence of the
effectiveness of collaborative care models for the
treatment of common mental disorders (CMDs) comor-
bid with chronic physical conditions from high-income
countries [11], there is little evidence of the effectiveness
of task-shared collaborative care models for physical and
mental multi-morbidity from LMICs.
The aim of this study was to evaluate an integrated
collaborative care package of care for chronic patients
with co-existing depressive and alcohol use disorder
(AUD) symptoms that strengthened identification and
management of these CMDs under real world conditions
through strengthened referral pathways in one case
study district in South Africa [12]. The study forms part
of the PRogramme for Improving Mental Health CarE
(PRIME) research consortium concerned with the devel-
opment, implementation and evaluation of integrated
packages of care for priority mental disorders at PHC
level in five LMIC countries [13]. The specific objectives
of this study were to assess primary outcomes of
whether the collaborative care package: i) improved
provider identification of depressive and AUD symptoms
in chronic care patients and ii) reduced depressive symp-
toms and improved functioning in screen positive
chronic patients identified and referred for care within
the task shared stepped up collaborative care model.
Secondary outcomes assessed effects in relation to
health equity criteria.
Methods
Setting
The study site was in the Matlosana municipality in Dr.
Kenneth Kaunda District (DKK) in the North West
Province. The district population was estimated to be
approximately 796,823 at the time of the study, while
the catchment areas where this study was located com-
prised over 90,000 people serviced by four primary
health care facilities varying in size, serving between
2353 and 6058 chronic care patients per month. Further
details of the DKK district can be found elsewhere [12].
Description of the collaborative mental health care
package
Details of the collaborative care package that was devel-
oped through the formative phase and evaluated by this
study are described in greater detail in Petersen et al.
[12]. In brief, it comprised the following five compo-
nents: i) PHC nurses functioned as case managers and
were oriented to the ICSM, trained in clinical communi-
cation skills to facilitate person-centered care, and
provided with supplementary mental health training in
basic adult care guidelines (known as Adult Primary
Care in South Africa) [14]; ii) Doctors were oriented to
the importance of mental health and upskilled to
prescribe antidepressant medications; iii) Referral path-
ways for psychosocial counselling for patients with mild
to moderate depressive symptoms were strengthened
with the introduction of clinic-based lay counsellors
trained and supervised to deliver individual and
group-based counselling drawing on cognitive behav-
ioural therapy techniques which have international
evidence of effectiveness [15]; and v) A referral form to
monitor nurse referrals to the counsellor was
introduced.
Research design
The research design was pragmatic with the intervention
delivered independently of the evaluation. Given the com-
plex nature of the collaborative care package, the evalu-
ation comprised two main components: i) a Facility
Survey to assess effects of the intervention on provider
detection of depression and AUD; and ii) a non-randomly
assigned comparison group cohort study to assess changes
in symptom severity and functioning among screen
positive patients identified and referred for further care by
the PHC nurses compared to those not identified.
Facility detection survey (FDS)
Study procedure, sample and measures
The primary objective of the Facility Detection Study
was to estimate the change in detection of depression
and of AUD by clinicians serving the adult chronic care
population in intervention clinics. The design and power
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calculations for the sample sizes are described in greater
detail elsewhere [16]. The FDS was conducted in three
of the four facilities where the mental health APC
module had not yet been implemented. The study proce-
dures used at baseline and follow-up FDS were the same,
with independent samples recruited in each study round.
The baseline FDS was conducted from February–April
2014, before the implementation of the intervention
began in April 2014. Training and embedding continued
to September 2014. The follow-up FDS was 12months
after completion of the embedding period (October–De-
cember 2015) (see Fig. 1).
Adult patients were recruited from the chronic care
waiting areas of the three PHC facilities by trained re-
cruiters who gave short oral presentations on the study.
No reference to mental health was made to minimize
sampling bias and limit stigma. Eligibility of patients
who volunteered was confirmed in a private space and
study objectives discussed. Eligibility criteria were: 18
years or older; attending the clinic for treatment for a
chronic illness (e.g., HIV, tuberculosis, hypertension, etc)
and capacity to understand the questions posed in either
seTswana (the dominant local language) or English. Writ-
ten informed consent was obtained from literate partici-
pants and illiterate participants consented by marking the
form with a cross; with a witness countersigning.
Trained fieldworkers administered a structured ques-
tionnaire, programmed into mobile devices. Questions
included items on demographic characteristics, treated
chronic condition(s), and screening instruments for prob-
able AUD and depression. The Alcohol Use Disorder
Identification Test (AUDIT), validated for use in South
Africa [17], was used to screen for probable AUD, with
participants scoring ≥16 considered positive for probable
AUD, given nurse guidelines to provide advice for harmful
drinking and refer patients with dependent drinking.
Cronbach’s alphas were 0.78 (baseline) and 0.74 (fol-
low-up). For probable depression, we used the Patient
Health Questionnaire-9 (PHQ-9), with a cut-off of ≥10
being previously validated on a primary care population in
South Africa [18]. Cronbach’s alphas were 0.88 (baseline)
and 0.86 (follow up).
All screen positive participants on either screening
tool, as well as 15% of randomly selected screen-negative
participants (both AUDIT and PHQ-9) were asked to
return for an exit interview immediately following their
clinical consultation.
Participants’ exit interview data were used to assess
clinical detection on the day of the interview. Broad cri-
teria were used to classify participants as detected for
AUD given our experience of nurse reticence to make a
diagnosis of AUD (patients who reported a diagnosis of
harmful or dependent drinking, and/or a referral to
specialist alcohol services, and/or who received advice
about managing problems with drinking alcohol). Two
classifications (narrow and broad) were used for detec-
tion of depression: narrow - a diagnosis of depression
was reported; broad – diagnosis of depression and/or
referral for psychosocial counselling reported. The latter
was included given our experience that nurses did not
always inform patients of a diagnosis of depression when
referring patients. Anti-depressant medication prescribed
was also assessed. Participants who reported being on
current treatment for either condition were excluded from
the analysis.
Statistical analyses
The socio-demographic and clinical characteristics of
the participants recruited over the two study rounds
were analyzed using means and standard deviations for
continuous measures and counts and proportions for
categorical measures. For each study round we report
the number of participants who screened positive on
AUDIT and PHQ-9, the number of screen positive
participants who completed the exit interview, and the
proportion who were classified as having been detected
for AUD (among AUDIT positive), or for depression
(among PHQ-9 positive) using both narrow and broad
criteria. For the equity analysis, where sufficient data
were available, we assessed whether change in detection
over time was equitable by sex and by household food
security. Both these demographic variables were shown
as having the highest odds ratios for depression/AUD
comorbidity in the same population in a previous study
[19]. For the inequity analysis, we used binomial regres-
sion models to estimate change in detection, and in-
cluded the relevant interaction term into the models,
with an interaction term p-value< 0.20 suggestive of
inequity. Second, for the screen negative PHQ-9 partici-
pants who were randomly selected to complete the exit
interview, we tabulated the number of depression
diagnoses and anti-depressant medication prescription.
When it was not possible to estimate the change in
detection because of zero counts in the baseline round,
we reported the proportion detected and 95% confidence
interval for the follow up round only. Procedures to
estimate proportions, 95% confidence intervals and
p-values incorporated weights to adjust for the imbal-
ance in clinic-level sample sizes between rounds [20].
Depression cohort study
Study procedure, sample and measures
Details of the sample size calculation, recruitment, ques-
tionnaire design, data collection procedures, and analysis
plan for the PRIME cohort studies have been described
in detail by Baron et al. [21] A cohort study for AUD
patients was not conducted in South Africa because of
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the very low levels of AUD identification by the pro-
viders in the baseline round of the FDS.
Eligible participants were at least 18 years old; receiv-
ing care for a chronic physical condition; screened posi-
tive for probable depression and/or had been identified
and referred for depression care by the providers; had
the capacity to provide informed consent and compre-
hend the interview; and did not have a diagnosis of AUD
or psychosis (see Fig. 2).
Chronic care patients were informed about the study
in the waiting areas of the clinics prior to their clinic con-
sultations and informed written consent was obtained
from volunteers. The same informed consent procedure
was followed for low-literacy patients as described for the
FDS. Immediately after their clinical consultations,
individuals who had given their consent were screened
using the PHQ-9, and asked whether, during the consult-
ation, they had been identified as having depression and/
or had been referred for care to a provider within the col-
laborative care model. Individuals who provided affirma-
tive responses to these questions were enrolled into the
depression treatment group, regardless of their PHQ-9
score. Individuals who did not provide affirmative
responses to these post consultation questions, but who
scored 10 or more on the PHQ-9 were enrolled into a
comparison group. Comparison group participants who
later received a depression diagnosis were re-enrolled in
the treatment group, and only the treatment group data of
these participants were analyzed (see Fig. 2).
Cohort study participants completed three assess-
ments: at enrolment (baseline); 3 months and 12-months
post-enrolment. Cohort recruitment and enrolment
occurred from August 2014 to July 2015, and follow-up
was conducted from November 2014 to September 2016
(see Fig. 1).
Mobile devices were used by trained seTswane/English
speaking fieldworkers to administer the questionnaire in
private spaces at the clinic or participants’ homes. Each
assessment comprised a range of demographic, clinical,
health care use, social, economic, food security, and
stigma-related measures. These are described in greater
detail by Baron et al. [21]. Only measures pertaining to
the socio-demographic and clinical characteristics of the
sample are reported here.
Primary outcomes of the cohort study were response
on the PHQ-9, defined as at least 50% reduction in score
from baseline to 3 months and 12months follow-up; and
remission on the PHQ-9 at both follow-up visits, defined
as a score of 5 or less - used as measures of clinically
significant improvement in treatment trials using the
PHQ-9, e.g. Huijbregts et al. (2013) [22]. Functional im-
pairment, was assessed at the three time points using
the 12-item WHO Disability Assessment Schedule
(WHODAS 2.0) - previously used in South Africa
amongst older and HIV populations [23]. Item response
theory (IRT)-based scoring was used, with scores ran-
ging from 0 to 100, with a higher score indicating
greater functional impairment.
Analysis
Given the non-normal distribution of the sample’s
demographic and clinical characteristics, baseline char-
acteristics of participants in the treatment and compari-
son groups were compared using non-parametric tests –
the Mann-Whitney U test for continuous measures, and
Exact Fisher’s test for categorical variables. The mean
symptom severity and functioning were compared be-
tween groups at each follow-visit. Given that neither
measure was normally distributed at follow-ups, a multi-
level mixed effect negative binomial regression was used,
controlling for HIV status and recruitment clinic, as
these were imbalanced at baseline [21]. Risk ratios for
the primary outcomes (i.e. 50% reduction in scores at 3
months and 12months follow-up, as well as remission)
were assessed using a modified Poisson regression, with
robust variance estimator, as binomial models failed to
converge [24]. Again, the models were adjusted for
demographic or other clinical differences between the
comparison and treatment groups at baseline. To assess
equity in primary outcomes across gender and house-
hold food security, the same negative binomial regres-
sions were conducted, this time including either gender
or household food security at baseline as an interaction
term.
Results
Facility detection survey
In the first round, 1322 participants were eligible and
consented to participate in the study. Twelve of these
were on current treatment for depression and excluded
from the study, resulting in a total of 1310 participants
at baseline. During the second round, 1257 were eligible
and consented to participate in the study; of these 11
were found to be on current treatment for depression
and excluded, resulting in a total of 1246 participants at
follow-up. The demographic and clinical characteristics
of the Facility Detection Survey participants are pre-
sented in Table 1.
Across both survey rounds, the mean age of the sam-
ple was 46 years; approximately three-quarters were
women; the majority were receiving care for HIV or
hypertension. There were significant between-round
differences in participants’ employment status, food
security, clinic site, and AUDIT screening.
For depression, as seen in Table 2(a), the pre-imple-
mentation diagnosis of depressive symptoms was 5.2%
using the narrow definition, and 14.2% using the
broader definition. Post-implementation, using the
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narrow definition, detection of depressive symptoms
reached 16.2%, an increase of 11.0% (95% CI 3.3,
18.6); using the broad definition, detection increased
to 26.7%, an increase of 12.5% (95% CI 1.9, 23.0). In
the inequity analysis, the change in detection for food
secure participants, using the broad definition, in-
creased to 33.8%, compared to 23.0% for food inse-
cure participants (P = 0.080). There was no evidence
of inequity (P = 0.656) for men versus women
participants.
For AUD, no AUDIT-positive participants were de-
tected in the pre-implementation round. In the
post-implementation round, 11.7% (95% CI 0.6, 22.8)
were detected. There were insufficient data for conduct-
ing inequity analyses for AUD detection and treatment.
As seen in Table 2(b), of the 1310 participants enrolled
in the pre-implementation round, 1084 screened nega-
tive on both PHQ-9 and AUDIT. Of the 1084, 118 were
selected randomly to complete the exit interview, and
110 were successfully interviewed after their consulta-
tions. Of the 110, 0.9% had been detected and treatment
initiated for depression using the narrow definition; and
6.7% using the broad definition. For AUD, 1.6% were
prescribed anti-depressant medication and 1.6% were
Table 1 Demographic and clinical characteristics of participants in PRIME implementation clinics, Matlosana sub-district, Northwest
Province, South Africa, 2014 & 2015
Pre-implementation (n = 1310) Post-implementation (n = 1246) p
Age, years (SD) 46.9 (13.3) 46.2 (13.5) 0.18
Female (%) 983 (75.0) 967 (77.6) 0.14
Marital status (%) 0.20
Single 405 (30.9) 358 (28.7)
Partnered 619 (47.2) 581 (46.6)
Divorced/Separated/Widowed 286 (21.8) 307 (24.6)
Education (%) 0.07
Never attended school 89 (6.8) 76 (6.1)
Some primary 320 (24.4) 261 (20.9)
Completed primary 720 (55.0) 705 (56.6)
Completed secondary 181 (13.8) 204 (16.4)
Employment Status (%) 0.01
Unemployed 519 (39.6) 513 (41.2)
Paid 505 (38.5) 521 (41.8)
Othera 286 (21.8) 212 (17.0)
Household food insecurity (%) 272 (20.8) 538 (43.2) 0.01
Clinic (%) 0.01
Grace Mokhomo 583 (44.5) 495 (39.7)
Kanana 274 (20.9) 342 (27.4)
Orkney 453 (34.6) 409 (32.8)
Chronic condition (%)
HIV 783 (59.8) 781 (62.8) 0.12
Hypertension 671 (51.2) 664 (53.4) 0.28
Diabetes 123 (9.4) 113 (9.1) 0.84
Arthritis 53 (4.1) 44 (3.5) 0.54
Chronic respiratory disease 56 (4.3) 31 (2.5) 0.02
Tuberculosis 73 (5.6) 13 (1.1) 0.01
Epilepsy 47 (3.6) 29 (2.3) 0.06
Screening (%)
PHQ-9 Screen Positive 107 (8.1) 130 (10.3) 0.056
AUDIT Screen Positive 43 (3.2) 63 (5.0) 0.03
P-value calculated with Fisher’s exact
aVoluntary, student, retired/pensioner, other
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diagnosed with AUD. These proportions did not change
significantly (all P > 0.05) between the pre- and
post-implementation surveys.
Depression cohort study
Of 2602 patients screened, a total of 453 participants
were enrolled in the cohort study. An initial 205 patients
were diagnosed with depression and recruited into the
treatment group. Another 248 patients were not diag-
nosed but screened positive on the PHQ-9, and were re-
cruited into the comparison group; of these, 12
participants were subsequently diagnosed with depres-
sion at a follow-up visit at the clinic, and re-enrolled
into the treatment group. The final sample was 236 for
the comparison group and 217 for the treatment group
(see Fig. 2).
There were 82 participants (18.1%) lost to follow-up,
mostly because of relocation and refusals. In the inter-
vention group, 88.9% (n = 193) participants were
followed at 3 months and 81.5% (n = 177) completed the
12-month assessment. In the comparison group, 88.6%
(n = 209) completed the midline assessment and 82.6%
(n = 195) the end-line assessment (see Fig. 1).
Of the 217 participants in the treatment group, 80 par-
ticipants screened below the clinical cut-off of 10 on the
PHQ-9 at baseline. These participants were excluded
from the analysis, to ensure that both treatment and
control groups were comparable. These participants did
not differ from those included in the analyses in terms
Table 2 Detection of Depression and Alcohol Use Disorder among chronic care patients in PRIME implementation clinics, Matlosana
sub-district, Northwest Province, South Africa, 2014 & 2015
Disorder Pre-implementation Post-implementation Detection difference (95% CI)a
a
Depression
Screened 1310 1246
Screen positive 106/1310 124/1246
Detection data available c 102/106 116/124
Detection-narrow* 6/102 (5.2) 19/116 (16.2) + 11.0 (3.3, 18.6)a
Detection-broad** 14/102 (14.2) 31/116 (26.7) + 12.5 (1.9, 23.0)a
Alcohol use disorder
Screened 1310 1246
Screen positive 42/1310 62/1246
Detection data available c 37/42 58/62
Detection 0/37 (0.0) 8/58 (11.7) 11.7 (0.6, 22.8)b
b. Screen negative patients
Screened 1310 1246
Probable non-case d 1084/1310 996/1246
Randomly Selected 118/1084 113/996
Detection data available 110/118 109/113
Depression
Detection-narrow e 1/110 (0.9) 2/109 (1.9)
Detection-broad f 8/110 (6.7) 8/109 (7.5)
Antidepressant prescribed 2/110 (1.6) 0/109 (0.0)
Alcohol use disorder
Detection 2/110 (1.6) 0/109 (0.0)
Counts are reported as observed, while proportions, differences, 95% confidence intervals and P-values are estimated with clinic-based weights
aEstimated with binomial regression
bEstimated as one-sample proportion
cCompleted post-consultation exit questionnaire
dScreen negative on PHQ-9 and AUDIT, and no depression symptoms over the past 12 months
eReported diagnosis of depression
fReported diagnosis or referral for psychosocial counselling
*Reported diagnosis of depression
**Reported diagnosis or referral for psychosocial counselling
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of demographic characteristics at recruitment, besides
food insecurity (Table 3). The final sample included in
the analysis comprised 373 participants: 137 and 236 in
the treatment and comparison groups, respectively.
Participants in the comparison and treatment groups
who were included in the analyses differed in terms of
clinic of recruitment and in HIV status (Table 3). Also,
participants recruited into the treatment group had
significantly higher PHQ-9 scores (mean = 14.5, SD =
3.47), compared to participants in the comparison group
(mean = 12.8, SD = 3.01).
Results of the modified Poisson regressions are
presented in Table 4. The proportion of participants
showing at least a 50% reduction in PHQ-9 scores from
baseline to the 3-month follow-up was greater in the
treatment group (N = 69, 55.2%) than in the comparison
group (N = 49, 23.4%; RR = 2.10, p < 0.001). The rate of
participants who showed remission on the PHQ-9
(score < 5) was also greater in the treatment group (N =
40, 32.0%) compared to the comparison group (N = 25,
12.0%; RR = 2.78, p < 0.001). The same significant trends
were found at the 12-month follow-up, with 57 (47.9%)
participants in the treatment group reporting at least
50% reduction in PHQ-9 score compared to baseline,
and 32 (26.9%) participants scoring below 5, compared
to 60 participants (30.8%; RR = 1.52, p = 0.006) and 33
participants (16.9%; RR = 1.72, p = 0.016) in the compari-
son group, respectively.
Table 3 Baseline demographic characteristics of the depression control and treatment cohorts included in the analysis
Excluded from analysis a Included in the analysis
Treatment (n = 80) Treatment (n = 137) Comparison (n = 236) p
Age, years (mean, SD) 44.8 (14.77) 42.6 (13.22) 44.0 (12.64) 0.469
Female (N, %) 61 (76.3%) 114 (83.2%) 190 (80.5%) 0.581
Marital status (N, %) 0.909
Single 22 (27.5%) 55 (40.2%) 90 (38.1)
Partnered 46 (57.5%) 59 (43.1%) 103 (43.6%)
Widowed/divorced 12 (15.0%) 23 (16.8%) 43 (18.2%)
Education (N, %) 0.405
No or some primary 24 (30.0%) 38 (27.7%) 60 (25.4%)
Completed primary 38 (47.5%) 80 (58.4%) 152 (64.4%)
Completed secondary 18 (22.5%) 19 (13.9%) 24 (10.2%)
Employment Status (%) 0.305
Unemployed 56 (70.0%) 102 (74.5%) 187 (78.2%)
Paid 24 (30.0%) 35 (25.5%) 49 (20.8%)
Food insecurity
No 60 (75.0%) 62 (45.3%) 102 (43.2%) 0.746
Yes 20 (25.0%) 75 (54.7%) 134 (56.8%)
Clinic (%) 0.005*
OR 10 (12.5%) 11 (8.0%) 21 (8.9%)
KA 16 (20.0%) 32 (23.4%) 93 (39.4%)
GM 38 (47.5%) 67 (48.9%) 77 (32.6%)
MJ 16 (20.0%) 27 (19.7%) 45 (19.1%)
Chronic condition (%)
HIV 26 (32.9%) 57 (41.6%) 173 (73.3%) < 0.001**
Hypertension 31 (39.2%) 53 (38.7%) 107 (45.3%) 0.233
Diabetes 3 (3.80%) 6 (4.4%) 15 (6.4%) 0.492
Other 9 (11.4%) 17 (12.4%) 24 (10.2%) 0.498
Main outcomes
PHQ-9 (mean, SD) 6.3 (2.15) 14.5 (3.47) 12.8 (3.01) < 0.001**
WHODAS (mean, SD) 24.1 (17.97) 37.6 (17.19) 40.0 (19.48) 0.251
a Diagnosed but scored < 10 on PHQ-9
*p = < 0.01; **p = < 0.001
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Table 4 PHQ-9 and WHODAS outcomes over time and across cohort groups
Control group Treatment group adjusted β or RR d
(95%CI)
p
N Mean score
(SD) or N (%)
Adjusted mean change
(95%CI) from baseline
N Mean score
(SD) or N (%)
Adjusted mean change
(95%CI) from baseline
Midline (3 months)a
Response on PHQ-9
b
209 49 (23.4%) – 125 69 (55.2%) – 2.10 (1.53 to 2.88) < 0.001
Remission on PHQ-9
c
209 25 (12.0%) – 125 40 (32.0%) – 2.78 (1.70 to 4.54) < 0.001
PHQ-9 score 209 9.6 (4.66) -2.63 (− 3.34 to − 1.92) 125 8.0 (6.16) −5.05 (− 6.02 to − 4.08) − 2.42 (− 3.49 to − 1.34) < 0.001
WHODAS score 209 34.7 (21.14) − 4.65 (−8.02 to − 1.28) 125 23.6 (20.99) − 11.11 (− 15.18 to −
7.05)
− 6.46 (− 11.37 to − 1.55) 0.010
Endline (12 months)a
Response on PHQ-9
b
195 60 (30.8%) – 119 57 (47.9%) – 1.52 (1.13 to 2.05) 0.006
Remission on PHQ-9
c
195 33 (16.9%) – 119 32 (26.9%) – 1.72 (1.11 to 2.68) 0.016
PHQ-9 score 195 9.0 (4.89) −3.10 (− 3.83 to − 2.37) 119 7.9 (5.17) −5.07 (− 6.05 to − 4.09) −1.97 (− 3.04 to − 0.90) < 0.001
WHODAS score 195 31.3 (22.39) −7.20 (− 10.68 to −
3.73)
119 28.4 (21.64) −8.00 (− 12.02 to − 3.99) −0.80 (− 5.68 to 4.07) 0.746
a Comparison group is the reference group; b defined as at least 50% reduction in score at follow-up compared to baseline; c defined as PHQ-9 < 5 at follow-up; d
RR = Risk ratio
Table 5 Equity analysis of Cohort Study
Control group Treatment group Difference of
difference
adjusted
β (95%CI)N Mean PHQ-9
score (SD)
Adjusted mean change in
PHQ-9 (95%CI) from baseline
N Mean PHQ-9
score (SD) or N (%)
Adjusted mean change in
PHQ-9 (95%CI) from baseline
Midline (3 months)
Sex
Male 43 8.3 (4.19) −3.56 (− 5.04 to − 2.08) 21 6.8 (4.98) −5.39 (− 7.45 to − 3.33) − 1.83 (− 4.28 to
0.62)
0.76
(− 1.94
to 3.45)
Female 166 9.9 (4.73) −2.41 (− 3.18 to − 1.64) 104 8.2 (6.36) −5.00 (− 6.03 to − 3.97) −2.59 (− 3.77 to
− 1.41)
Household food insecurity
Food
secure
89 8.7 (4.20) −2.89 (− 3.92 to − 1.86) 58 6.2 (4.84) − 6.62 (− 7.95 to − 5.28) −3.73 (− 5.30 to
− 2.15)
− 2.50 a
(− 4.60 to
− 0.41)
Food
insecure
120 10.3 (4.88) −2.56 (− 3.47 to − 1.65) 67 9.5 (6.79) −3.79 (− 4.98 to − 2.59) −1.23 (− 2.65 to
0.20)
Endline (12 months)
Sex
Male 38 7.3 (4.29) −4.44 (− 5.94 to − 2.94) 21 7.7 (4.34) − 4.64 (− 6.72 to − 2.56) −0.20 (− 2.67
to 2.28)
2.18
(− 0.55
to 4.91)
Female 157 9.4 (4.95) −2.80 (− 3.59 to − 2.01) 98 8.0 (5.35) −5.17 (− 6.22 to − 4.13) −2.38 (− 3.55
to − 1.20)
Household food insecurity
Food
secure
86 8.3 (4.81) −3.27 (− 4.31 to − 2.24) 55 6.5 (4.97) −6.42 (− 7.76 to − 5.08) −3.15 (− 4.72
to − 1.58)
− 2.24 a
(− 4.34 to
− 0.14)
Food
insecure
109 9.6 (4.91) − 3.10 (− 4.04 to − 2.17) 64 9.2 (5.06) −4.01 (− 5.22 to − 2.81) −0.91 (− 2.33
to 0.52)
a Significant at < 0.05 level
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Change in mean scores on the PHQ-9 and WHODAS
over time are also presented in Table 4. After controlling
for HIV status and clinic of recruitment, the mixed
effects analyses reveal a significant difference between
the two groups at the 3-month follow-up; a greater
decrease in PHQ-9 scores in the treatment group (M
= -5.05, 95%CI: -6.02 to − 4.08) compared to the com-
parison group (M = -2.63, 95%CI: -3.34 to − 1.92; β = −
2.42, p < 0.001) and a greater decrease in WHODAS
scores from baseline in the treatment group (M = -11.11,
95%CI: -15.18 to − 7.05) compared to the comparison
group (M = -4.65, 95%CI: -8.02 to − 1.28; β = − 6.46, p =
0.010). A similar trend was seen for the PHQ-9 scores at
the 12-month follow-up compared to baseline (treat-
ment: M = -5.07, 95%CI: -6.05 to − 4.09; comparison: M
= -3.10, 95%CI: -3.83 to − 2.37, β = − 1.97, p < 0.001).
The change in WHODAS scores at the 12-month
follow-up was not significantly different between the two
groups.
Inequity analyses of the impact of the intervention on
outcomes by gender and household food security are pre-
sented in Table 5. There is no evidence of inequity by gen-
der at either follow-up time points. At 3months
follow-up, however, the intervention was found to have a
significantly more positive effect on reducing depressive
scores among participants who reported being food secure
at baseline (β = − 3.73, 95%CI -5.30 to − 2.15) (M= − 6.62,
95% CI: -7.95—5.28) compared to those reporting being
food insecure (β = − 1.23, 95%CI -2.65 to 0.20; β = − 2.50,
p < 0.05). This trend persisted at 12months follow-up.
Discussion
The results of the FDS suggest an improvement in
nurse-detection and treatment initiation of depressive and
AUD symptoms following implementation of the integrated
collaborative care package in the district. Notably, identifi-
cation remained essentially absent for individuals who were
probable non-cases. In other words, the positive predictive
value of nurse identification and treatment initiation was
high for both depression and AUD.
The results of the cohort study indicate that patients
correctly identified and referred for further care for their
depressive symptoms had a greater chance of having a
clinically significant reduction in depressive symptoms
to the point of being in remission at both 3 and 12
month follow-up than those not referred. They also
showed a significant reduction in functional disability at
3-month follow-up compared to the non-intervention
group, although this effect was not sustained at 12
months. The intervention was significantly more suc-
cessful with food secure participants, suggesting that
food insecurity, may serve as a barrier to improvement
in depressive symptoms; being associated with poverty
in more urban areas in South Africa [25]. This adds to
the growing body of evidence suggesting the need for ac-
companying income generating initiatives for people
with depressive symptoms from poor socio-economic
contexts [26].
While an improvement in the correct identification
and treatment initiation of patients with depressive and
AUD symptoms was noted, the treatment gap post train-
ing still remained large, with 75% of probable cases of
depression and 84% of probable cases of AUD still not
detected at 12 months follow-up. Previous studies sug-
gest that training alone may be insufficient to improve
identification of CMDs in PHC [27]. Other factors con-
tributing to this gap resonate with our understanding of
possible reasons and include individual provider level
factors - with psychiatric stigma as well as providers’
own personal unresolved problems previously shown to
act as barriers to the identification of emotional prob-
lems in patients [28, 29]. The inclusion of anti-stigma in-
terventions [28], stress management and debriefing
sessions to assist PHC personnel to engage in emotional
labour has been previously suggested to assist integra-
tion efforts [29]. Further, the need for change manage-
ment processes to accompany organizational changes
associated with integrated care has also previously been
highlighted [8].
Limitations
There are a number of limitations of this evaluation.
With regard to the FDS: i) Non-random sampling
compromised the representativeness of the sample. An
imbalance in the demographics between the two rounds
was noted – with an upward trend in food insecurity,
unemployment and alcohol screen positives in the sec-
ond round - partially explained by retrenchments on the
mines between the two survey rounds, with mining
being a major industry and source of employment in the
study site; ii) There were no control clinics involved in
the FDS – with the possibility that the some of the
improvements in detection were due to other factors in
the health system; iii) An upwards bias in detection may
have been introduced given patients’ heightened aware-
ness of their potential symptoms through exposure to
the survey interview prior to their consultation - al-
though offset by being the case for both rounds as well
as having screen-negative cases; and iv) The FDS only
assessed clinical detection on the day of the interview –
with diagnosis of a CMD generally taking several visits
[27] – thus potentially under-representing detection
rates. In relation to the cohort study, recruitment into
the intervention and control arm was not randomized,
thus increasing potential for bias from unknown con-
founders, although partially mitigated by multi-variable
analyses.
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Conclusion
This evaluation shows that the PRIME-SA intervention
package assisted PHC teams to identify and manage
comorbid CMDs in chronic patients under real world
conditions using a collaborative stepped care model.
There was an improvement in accurate detection of
CMDs by PHC nurses, and a reduction in depressive
symptoms in patients identified with comorbid depres-
sion and referred for care. Further research is required
to assess patient outcomes in patients with comorbid
AUD. In the face of the negative impact that comorbid
CMDs have on treatment adherence and overall health
outcomes in chronic patients, this collaborative task
shared model provides a potential model for mental
physical multi-morbid disease management in South
Africa and other LMICs in the context of specialist
resource shortages. Additional findings will be provided
by two parallel pragmatic cluster randomized control
trials that are currently underway, testing effectiveness
of this model on depression and physical outcomes (viral
load suppression in HIV patients and reductions in
blood pressure in hypertensive patients) in chronic care
patients [30, 31].
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